Protein S, a vitamin K-dependent plasma protein, is a cofactor for protein C, an essential component of the regulatory system of coagulation. We describe the anaesthetic management of a parturient with protein S deficiency and an indwelling lumboperitoneal shunt, which was placed following transverse and sagittal sinus thrombosis. She was treated with aspirin and enoxaparin during pregnancy and underwent caesarean section under general anaesthesia without complication.
Protein S is a vitamin K-dependent non-enzymatic co-factor for activated protein C. It circulates in plasma as free protein S and in reversible complex with complement component C4b binding protein. Free protein S is a cofactor for activated protein C and exerts anticoagulant activity 1 . The clinical relevance of protein S is demonstrated by the increased thrombotic tendency of individuals with protein S deficiency 2 . This is exacerbated during pregnancy because the plasma concentration of protein S is depressed, reaching a nadir at the time of delivery 3 .
Cerebrospinal fluid (CSF) shunts are used to treat raised intracranial pressure unresponsive to conservative management and more women with CSF shunts are surviving to childbearing age. We describe the anaesthetic management of caesarean section in a patient with documented protein S deficiency that had caused transverse and sagittal sinus thrombosis, for which a lumboperitoneal shunt had been placed. There are no previous reports of the anaesthetic management of a patient with protein S deficiency and a lumboperitoneal shunt.
CASE HISTORY
A 31-year-old woman, gravida 2, para 0, at 38 weeks gestation, with protein S deficiency and an indwelling lumboperitoneal shunt, was scheduled for elective caesarean section. She weighed 65 kg and was 147 cm tall. Her past medical history included intracranial transverse and sagittal sinus thrombosis, with raised intracranial pressure and optic nerve dysfunction, at the age of 23 years. She had been unresponsive to medical therapy (serial lumbar punctures, steroids and diuretics) but was successfully treated with the placement of a lumboperitoneal shunt at the L3-4 intervertebral space. The patient was subsequently commenced on aspirin therapy. She also had a history of a missed abortion at ten weeks gestation, one year previously. Intrauterine foetal death was possibly attributable to protein S deficiency, because functional protein S measured by photodetection of clot was low (61%, normal range 70% to 140%). Inter-conceptional functional protein S concentration was also low (65%). During the present pregnancy, her functional protein S was 52% at six weeks gestation. After consulting the neurologist and haematologist, she was started on a thromboprophylactic regimen of enoxaparin, a low molecular weight heparin (LMWH) 40 mg subcutaneously and oral aspirin 75 mg once daily. Functional protein S at 18, 22 and 28 weeks gestation remained below normal (Table 1) .
Platelet count and coagulation profile were monitored every four weeks and remained within normal limits. She had not had a thrombosis during her current pregnancy.
Elective caesarean section was planned at 38 weeks gestation, the indication being severe cephalopelvic disproportion. Aspirin was stopped one week before the planned date of surgery and enoxaparin was administered 12 hours before her scheduled time of surgery. The patient was apprehensive about regional anaesthesia because of her past experience of multiple lumbar punctures. The presence of a lumboperitoneal shunt added to our concern and we chose general anaesthesia. After preoxygenation, anaesthesia was induced with thiopentone sodium 250 mg intravenously. Tracheal intubation was facilitated by suxamethonium 100 mg. Isoflurane 0.5% with oxygen in nitrous oxide 50:50 was used for maintenance of anaesthesia. Neuromuscular blockade was achieved with atracurium 35 mg. After delivery of a 2.35 kg female child, fentanyl 100 µg intravenously was administered. Blood pressure and body temperature were maintained within the normal range. All intravenous fluids were warmed to 37°C before infusion.
Surgery and anaesthesia were uneventful. Enoxaparin was restarted six hours after surgery and continued for six weeks. Peripartum antibiotics were administered prophylactically to prevent infection. The concentration of protein S was still low following delivery. No coagulation problems occurred postoperatively and two months later the concentration of functional protein S had returned to prenatal levels. The infant had a normal coagulation profile and no protein S deficiency.
DISCUSSION
Protein C inhibits the coagulation cascade by inactivating factors Va and VIIIa 4 and accelerates clot lysis, whilst protein S, the cofactor of protein C, enhances this property of anticoagulation 5 . A physiological decrease in total and free protein S is seen in pregnancy and the post partum period, predisposing to venous thrombosis. Women with inherited thrombophilic disorders have a much higher risk of pregnancy-related venous thromboembolism than women without these disorders. In women with antithrombin III, protein C and protein S deficiencies, the inci-dence of venous thromboembolism during pregnancy and post partum is estimated to be 40%, 15% and 11% respectively, compared with 0.5% for nondeficient pregnant women 6 .
In our patient, there was a past history of transverse and sagittal sinus thrombosis and hence the possibility of recurrent thrombosis during the pregnancy was increased. In order to prevent spontaneous abortion and decrease this risk, thromboprophylaxis is advocated in these patients 7 . Because of the maternal and foetal risks associated with the use of warfarin in pregnancy, subcutaneous heparin is used for obstetric thromboprophylaxis. The most obvious advantage of low molecular weight heparin (LMWH) in obstetrics is the increased bioavailability and longer half-life, which together allow for once daily administration 8 . Our patient had been on low dose aspirin therapy for eight years following sinus thrombosis and enoxaparin was started early in the pregnancy.
There are potential dangers of bleeding during regional anaesthesia in the anticoagulated patient. During therapeutic anticoagulation, spinal anaesthesia appears to be a real risk for the development of intraspinal haemorrhage [9] [10] [11] . Central neuraxial techniques should be withheld in patients treated with therapeutic doses of heparin 12 . On the other hand, the large number of patients simultaneously receiving prophylactic low dose unfractionated heparin or LMWH and epidural or spinal anaesthesia 13 has established the safety of the technique. Regional block should be delayed four to six hours from the last dose of unfractionated heparin and 12 hours after LMWH 14 . Many patients on heparin prophylaxis will benefit from epidural anaesthesia, however the risks and benefits need to be assessed individually in each patient. Irrespective of the anaesthetic technique, decreased cardiac output, deliberate hypotension, intraoperative hypovolaemia, excessive blood loss and hypothermia should be avoided in patients with protein S deficiency. All increase the risk of thrombosis 7 . LMWH should be continued for six weeks post partum 8 .
The second risk factor in our patient was the presence of a lumboperitoneal shunt. The major concerns when caring for a parturient with a CSF shunt are the present control of intracranial pressure, the functioning of the shunt, the risk of tonsillar herniation in the case of dural puncture, the risk of infection (meningitis) and shunt malfunction following regional analgesia/anaesthesia, and the management of postpartum headache 15 successfully received regional analgesia/anaesthesia for vaginal and operative delivery 16 . The placement of an epidural catheter should be accomplished with extreme care to avoid dural puncture, thereby preventing potential contamination of the CSF and alteration of differential pressure 17 . Some authors have expressed concern regarding the use of neuraxial block in patients with lumboperitoneal shunt, because of the possibility of trauma to the shunt, the potential loss of local anaesthetic into the peritoneal cavity (spinal anaesthesia) 18, 19 and the risk of knotting the epidural catheter with the lumboperitoneal shunt 20 . In view of these risks, we chose general anaesthesia over regional anaesthesia for our patient. Caesarean delivery may increase the risk of abdominal infection and adhesion formation around the distal end of the shunt. Great care should be taken to thoroughly flush the peritoneal cavity in an attempt to decrease the risk of intra-abdominal infection 16 . Although the role of prophylactic antibiotic therapy is not yet fully known, we considered the potential benefits to outweigh the risks, and peripartum antibiotics were administered.
In summary, protein S deficiency is an uncommon disorder resulting in recurrent venous thrombosis. Our parturient had protein S deficiency and an indwelling lumboperitoneal shunt. A team approach involving anaesthetists, obstetricians, haematologists and neurologists is required in order to select the most appropriate management options for parturients with protein S deficiency and indwelling CSF shunts.
